May 22, 2024 — Results of a small study showed that a whole-food, plant-based diet followed by women with stage 4 breast cancer improved several measures of health, including levels of cancer ...
Poor diet and gut health are leaving the UK facing a surge in cancer cases in the under-50s, research suggests. More young people than ever are getting cancer, with diagnosis rates rising by a ...
May 28, 2024 — Heart disease is the leading cause of death among men, and being a father may put men at an even greater risk of poor heart health later in life, reports a new study. The study of ...
A new study suggests that combining intermittent fasting with high-intensity functional training produces better weight ...
Share on Pinterest New research suggests that Zepbound is effective for weight loss regardless of the number of obesity-associated diseases a person may have ...
Type 2 diabetes, arthritis, stroke - these are all serious health conditions normally associated with getting older. But, ...
Share on Pinterest Semaglutide drug use were linked to better kidney health in people with obesity and established heart disease in a new study. Image credit: Iuliia Burmistrova/Getty Images.
More than 11% of children in the US have received an ADHD diagnosis in 2022, according to a new study Marina Watts is a Digital News Editor at PEOPLE. She has been working at PEOPLE since 2024.
Washington: Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are ...
Share on Pinterest A study has found semaglutide sold under brand names Ozempic and Wegovy may lower kidney disease risk. Iuliia Burmistrova/Getty Images Popular GLP-1 drug semaglutide may help ...
The popular weight-loss drug Wegovy has been available in Canada since early May, but anybody hoping to use it will have to shell out about $400 a month. One advocate says that lack of ...